Your browser doesn't support javascript.
loading
Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias.
Dunford, Andrew; Weinstock, David M; Savova, Virginia; Schumacher, Steven E; Cleary, John P; Yoda, Akinori; Sullivan, Timothy J; Hess, Julian M; Gimelbrant, Alexander A; Beroukhim, Rameen; Lawrence, Michael S; Getz, Gad; Lane, Andrew A.
Afiliación
  • Dunford A; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Weinstock DM; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Savova V; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Schumacher SE; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Cleary JP; Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
  • Yoda A; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Sullivan TJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Hess JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Gimelbrant AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Beroukhim R; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Lawrence MS; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Getz G; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Lane AA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Nat Genet ; 49(1): 10-16, 2017 01.
Article en En | MEDLINE | ID: mdl-27869828
ABSTRACT
There is a striking and unexplained male predominance across many cancer types. A subset of X-chromosome genes can escape X-inactivation, which would protect females from complete functional loss by a single mutation. To identify putative 'escape from X-inactivation tumor-suppressor' (EXITS) genes, we examined somatic alterations from >4,100 cancers across 21 tumor types for sex bias. Six of 783 non-pseudoautosomal region (PAR) X-chromosome genes (ATRX, CNKSR2, DDX3X, KDM5C, KDM6A, and MAGEC3) harbored loss-of-function mutations more frequently in males (based on a false discovery rate < 0.1), in comparison to zero of 18,055 autosomal and PAR genes (Fisher's exact P < 0.0001). Male-biased mutations in genes that escape X-inactivation were observed in combined analysis across many cancers and in several individual tumor types, suggesting a generalized phenomenon. We conclude that biallelic expression of EXITS genes in females explains a portion of the reduced cancer incidence in females as compared to males across a variety of tumor types.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Genes Supresores de Tumor / Cromosomas Humanos X / Inactivación del Cromosoma X / Genes Ligados a X / Sexismo / Mutación / Neoplasias Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Genes Supresores de Tumor / Cromosomas Humanos X / Inactivación del Cromosoma X / Genes Ligados a X / Sexismo / Mutación / Neoplasias Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos